Over 30 million J&J vaccines expected from Aspen facility

View descriptionShare
Published Mar 30, 2021, 5:06 AM

Thirty one million Johnson & Johnson Covid-19 vaccines are set to be produced at Aspen Pharmacare’s manufacturing plant in Gqeberha. Bongani speaks to Stavros Nicolaou, Senior Executive of Strategic Trade at Aspen.

  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. The Best of Breakfast with Bongani Bingwa

    5129 clip(s)

Breakfast with Bongani Bingwa

The highlights from each day's breakfast show with Bongani Bingwa.
Social links
Recent clips
Browse 9741 clip(s)